JAGSONPAL PHARMACEUTICALS LTD. reported Q3FY25 revenue of 740 million with a 57% increase compared to Q3FY24, alongside a business PAT of 115 million, up from 40 million last year.
AI Assistant
Jagsonpal Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.